United States · FDA National Drug Code directory
Palynziq
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68135-058_b7b7caec-2808-4d88-ae34-1129a2cb1aef
- Product NDC
- 68135-058
- Form
- INJECTION, SOLUTION
- Composition / generic term
- pegvaliase-pqpz
- Labeler
- BioMarin Pharmaceutical Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180524
- Source listing expiry
- 20271231
Source-listed ingredients
- PEGVALIASE — 2.5 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (68135-058-90) / .5 mL in 1 SYRINGE (68135-058-89) · 68135-058-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →